Início › HIV › Texas › Houston
Ensaios clínicos de HIV em Houston, TX
17 estudos para HIV estão buscando participantes em locais em Houston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
RecrutandoEstudo observacional
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RecrutandoFase 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Recrutando
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
RecrutandoFase 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · a 7 mi de distância
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
RecrutandoFase 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RecrutandoFase 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
RecrutandoFase 1Voluntários saudáveis bem-vindos
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Recrutando
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Recrutando
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
RecrutandoVoluntários saudáveis bem-vindos
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
RecrutandoFase 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RecrutandoFase 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · a 7 mi de distância
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Recrutando
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
RecrutandoFase 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Recrutando
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RecrutandoFase 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RecrutandoFase 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Ensaios de HIV em outras cidades
- Washington, DC22 estudos
- New York City, NY19 estudos
- Miami, FL17 estudos
- Baltimore, MD16 estudos
- San Francisco, CA15 estudos
- Atlanta, GA14 estudos
- Chicago, IL14 estudos
- Boston, MA11 estudos
- Philadelphia, PA11 estudos
- San Diego, CA10 estudos
- Los Angeles, CA9 estudos
- Seattle, WA8 estudos
Outros estudos em Houston
- Câncer de Pulmão de Não Pequenas Células145 estudos
- Câncer de Mama126 estudos
- Câncer (todos os tipos)121 estudos
- Câncer Metastático104 estudos
- Câncer Colorretal102 estudos
- Câncer de Ovário89 estudos
- Leucemia Mieloide Aguda85 estudos
- Câncer de Pulmão78 estudos
- Câncer de Próstata76 estudos
- Câncer Endometrial68 estudos
- Câncer de Pâncreas61 estudos
- Melanoma59 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.